5HT2A antagonist to combat fatty liver diseaseMetabolic dysfunction-associated steatotic liver disease (MASLD) is a burgeoning global health concern, posing a significant threat to...
ABS and AOBS agree Focused Practice Designation for metabolic and bariatric surgery examination19 hours ago